Diagnostic Accuracy of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Serum of Patients with Pleural Effusion
Iraqi Journal of Medical Sciences · 29.06.2026 · 24 (1) · 154-161
DOI: 10.22578/ba95jn03 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iraqi Journal of Medical Sciences, online erschienen am 29.06.2026. Verfasst von Noor H. Jumaa und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Pleural effusion (PE) is an abnormal buildup of fluid in the pleural space that typically results from excessive fluid production and/or reduced lymphatic absorption. It is still difficult to distinguish between benign and malignant exudative PE in clinical settings. Matrix metalloproteinase-9 (MMP-9) is linked to tumor aggressiveness and the potential for metastasis. It also plays a part in chronic inflammation. Numerous studies have shown that MMP-9 may be a useful marker to distinguish between benign and malignant exudative PE.
Objective
To assess the diagnostic utility of tissue inhibitor of metalloproteinase-1 (TIMP-1) and MMP-9 in separating benign from malignant exudative PEs.
Methods
A case-control study comprised 60 patients with malignant PEs and 60 patients with benign PEs who visited Al-Imamein Al-Kadhimein Medical City. All patients were examined and asked about their medical history, and they had measured the serum level of MMP-9 and TIMP-1 as markers for differentiation between benign and malignant exudative pleural effusion. It was determined by using quantitative sandwich (ELISA) technique.
Results
The levels of MMP-9 and TIMP-1 in the serum of patients with malignant PE are higher than in benign PE, with a sensitivity of MMP-9 and TIMP-1 (60% and 56.67%), specificity (93.33% and 95%), AUC (0.774 and 0.782) and the optimal cutoff value was >11.784 ng/ml and 1089.19 pg/ml) respectively with p-value ˂0.001.
Conclusion
MMP-9 and TIMP-1 might be valuable markers in differentiating benign from malignant PEs.Keywords Exudative pleural effusion, lactate dehydrogenase, matrix metalloproteinase-9, tissue inhibitor metalloproteinase-1.
Zitieren
APA
Jumaa, N. H., Baban, R. S., Al-Haibi, Y. A. E., & Qader, A. H. (2026). Diagnostic Accuracy of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Serum of Patients with Pleural Effusion. Iraqi Journal of Medical Sciences, 24(1), 154-161. https://doi.org/10.22578/ba95jn03
Vancouver
Jumaa NH, Baban RS, Al-Haibi YAE, Qader AH. Diagnostic Accuracy of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Serum of Patients with Pleural Effusion. Iraqi Journal of Medical Sciences. 2026;24(1):154-161. doi:10.22578/ba95jn03
BibTeX
@article{Jumaa2026,
author = {Jumaa, Noor H. and Baban, Rayah S. and Al-Haibi, Yaser A. E. and Qader, Ameerah H.},
title = {Diagnostic Accuracy of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Serum of Patients with Pleural Effusion},
journal = {Iraqi Journal of Medical Sciences},
year = {2026},
volume = {24},
number = {1},
pages = {154--161},
doi = {10.22578/ba95jn03}
}
EUVIMED